Extracellular Vesicle technology opens the window for a new diagnostic platform to identify disease. The use of Aegle extracellular vesicles would not change the mechanisms used by current diagnostic processes, but allow for more accurate sources for testing. It is known that extracellular vesicles carry the specific signatures of diseases. Aegle technology enables extracellular vesicles to be concentrated, potentially making testing easier and more efficient. Aegle anticipates it will seek to partner or sublicense its rights to diagnostic products.